Hansen has announced the completion of the first robot-assisted uterine fibroid embolization in the USA. Sandeep Rao, interventional radiologist, performed the procedure at Sierra Medical Center in El Paso, Texas, using the Magellan Robotic System.
“I am extremely pleased by the outcome of this initial procedure,” said Rao. “Robotic catheters have the potential to provide enhanced control and precision, especially in the small, often tortuous blood vessels involved in uterine fibroid embolization. The Magellan system enables us to offer a compelling, non-surgical, robotic treatment option for a condition affecting a large number of women.”
Approximately 30,000 uterine fibroid embolization procedures are performed in the United States annually. While robot-assisted uterine fibroid embolization procedures have been performed in Europe with the Magellan system, this week’s procedure at Sierra Medical Center was the first in the USA.
The Magellan Robotic System offers physicians robotic catheter control and stability during complex procedures in the peripheral blood vessels, and is used by physicians worldwide in a wide variety of catheter-based procedures. With the recent FDA 510(k) clearance for the smaller diameter Magellan 6F Robotic Catheter, physicians are now able to perform robotic procedures in smaller blood vessels, including those accessed during a uterine fibroid embolization procedure.
